Figure 2.
Incidence of any denial of a direct-acting antiviral (DAA) prescription by the insurer (overall height of bar), insurer denial of a DAA prescription preceding approval (light gray bar), and absolute denial of a DAA prescription by the insurer (dark gray bar), overall and by insurance status.